ALKS - Alkermes plc
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $0.43
|
Rev Est: $380.4M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$46.38
DETAILS
HIGH:
$56.00
LOW:
$43.00
MEDIAN:
$45.00
CONSENSUS:
$46.38
UPSIDE:
38.90%
Market Cap:
5.51B
Volume:
2,161,192
Avg Volume:
1,855,121
52 Week Range:
25.17-36.32
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.46
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
IE
Employees:
1,800
IPO Date:
1991-07-16
EPS (TTM):
2.22
P/E Ratio:
12.96
Revenue (TTM):
1.56B
Total Assets:
2.06B
Total Debt:
75.54M
Cash & Equiv:
291.15M
Rev Growth (5Y):
5.9%
EPS Growth (5Y):
23.5%
FCF Growth (5Y):
N/A
ROCE:
29.3%
Debt/Equity:
0.05
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-10-28 | $0.49 | $0.42 | +16.7% | $394.2M | $379.9M | +3.8% |
| 2025-07-29 | $0.52 | $0.41 | +26.8% | $390.7M | $354.5M | +10.2% |
| 2025-05-01 | $0.13 | $0.25 | -48.9% | $306.5M | $302.9M | +1.2% |
| 2025-02-12 | $1.04 | $0.81 | +28.4% | $430.0M | $379.4M | +13.3% |
| 2024-10-24 | $0.72 | $0.74 | -2.7% | $378.1M | $381.4M | -0.8% |
| 2024-07-24 | $0.70 | $0.70 | 0.0% | $399.1M | $382.8M | +4.3% |
| 2024-05-01 | $0.44 | $0.59 | -25.4% | $350.4M | $393.4M | -10.9% |
| 2024-02-15 | $0.48 | $0.46 | +4.3% | $377.5M | $377.0M | +0.1% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.56B | 1.66B | 1.11B | 1.17B | 1.04B | 1.17B | 1.09B | 903.37M | 745.69M | 628.34M | 618.79M | 575.55M |
| Net Income | 367.07M | 355.76M | (158.27M) | (48.17M) | (110.86M) | (196.62M) | (139.31M) | (157.94M) | (208.44M) | (227.16M) | (30.06M) | 24.98M |
| EPS | 2.22 | 2.14 | -0.97 | -0.30 | -0.70 | -1.25 | -0.90 | -1.03 | -1.38 | -1.52 | -0.21 | 0.19 |
| Total Assets | 2.06B | 2.14B | 1.96B | 2.02B | 1.95B | 1.81B | 1.83B | 1.80B | 1.73B | 1.86B | 1.92B | 1.47B |
| Total Debt | 75.54M | 372.19M | 379.44M | 416.21M | 410.16M | 290.95M | 279.31M | 281.44M | 283.67M | 349.94M | 357.97M | 369.01M |
| Cash & Equivalents | 291.15M | 457.47M | 292.47M | 337.54M | 272.96M | 203.77M | 266.76M | 191.30M | 186.38M | 181.11M | 224.06M | 96.96M |
| Operating Cash Flow | 439.12M | 401.35M | 21.04M | 101.72M | 82.84M | 72.08M | 99.28M | 19.19M | (63.80M) | (40.36M) | 11.14M | 126.55M |
| Free Cash Flow | 405.64M | 353.31M | (17.21M) | 72.69M | 40.62M | (18.86M) | 29.85M | (32.11M) | (107.46M) | (93.24M) | (22.51M) | 104.33M |
| FCF per Share | 2.45 | 2.13 | -0.11 | 0.45 | 0.26 | -0.12 | 0.19 | -0.21 | -0.71 | -0.62 | -0.15 | 0.79 |
| Book Value | 1.46B | 1.20B | 1.04B | 1.11B | 1.07B | 1.09B | 1.17B | 1.20B | 1.21B | 1.31B | 1.40B | 952.37M |
| Cash & ST Investments | 751.67M | 773.49M | 608.47M | 536.31M | 635.03M | 534.98M | 539.29M | 590.72M | 619.16M | 798.85M | 801.65M | 221.35M |
| ROC Equity | 0.25 | 0.30 | -0.15 | -0.04 | -0.10 | -0.18 | -0.12 | -0.13 | -0.17 | -0.17 | -0.02 | 0.03 |